Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis
Crossref DOI link: https://doi.org/10.1007/s13555-020-00454-z
Published Online: 2020-10-13
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bagel, Jerry http://orcid.org/0000-0001-5241-0915
Nelson, Elise
Zapata, James
Hetzel, Alexa
Funding for this research was provided by:
LEO Pharma
Text and Data Mining valid from 2020-10-13
Version of Record valid from 2020-10-13
Article History
Received: 25 August 2020
First Online: 13 October 2020